The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial. Issue 5 (11th March 2020) - Opingari, Erika; Verma, Subodh; Connelly, Kim A; Mazer, Cyril David; Teoh, Hwee; Quan, Adrian; Zuo, Fei; Pan, Yi; Bhatt, Deepak L; Zinman, Bernard; Leiter, Lawrence A; Yan, Andrew T; et al.